Metabolic Effects of β-Adrenoceptor Antagonists with Special Emphasis on Carvedilol

By Kveiborg Britt   Christiansen Buris   Major-Petersen Atheline   Torp-Pedersen Christian  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 4, 2006-01 ,pp. : 209-217

Adis International

Access to resources Recommend Favorite

β-Adrenoceptor polymorphisms

By Leineweber K.   Büscher R.   Bruck H.   Brodde O.-E.  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 1, 2004-01 ,pp. : 1-22

Springer Publishing Company

Access to resources Recommend Favorite

Profiling of cardiac β-adrenoceptor subtypes in the cardiac left ventricle of rats with metabolic syndrome: Comparison with streptozotocin-induced diabetic rats

By Okatan Esma N.   Tuncay Erkan   Hafez Gaye   Turan Belma  

Canadian Journal of Physiology and Pharmacology, Vol. 93, Iss. 7, 2015-01 ,pp. : 517-525

NRC Research Press

Access to resources Recommend Favorite

Pediatric Heart Failure Therapy with β-Adrenoceptor Antagonists

By Foerster Susan R.   Canter Charles E.  

Pediatric Drugs, Vol. 10, Iss. 2, 2008-01 ,pp. : 125-134

Adis International

Access to resources Recommend Favorite

Functional characterisation of the pharmacological profile of the putative 1B -adrenoceptor antagonist, (+)-cyclazosin

By Stam W.B.   Van der Graaf P.H.   Saxena P.R.  

European Journal of Pharmacology, Vol. 361, Iss. 1, 1998-11 ,pp. : 79-83

Elsevier

Access to resources Recommend Favorite